Thus, a valuable approach for preventing recurrence of surgically resected CRC could be the use of surgically resected own cancer cells for immunization to activate CD8+ cytotoxic T cells specific to their own cancer cells. The gene discussed is CD8A; the disease is colorectal carcinoma.